Literature DB >> 526393

Labetalol in the treatment of patients with hypertension and renal function impairment.

R R Bailey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 526393      PMCID： PMC1429743     

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  8 in total

1.  The kidney and antihypertensive therapy.

Authors:  R R Bailey
Journal:  Drugs       Date:  1976       Impact factor: 9.546

2.  Labetalol in the treatment of hypertensive renal patients.

Authors:  J G Williams; K De Voss; P W Craswell
Journal:  Med J Aust       Date:  1978-02-25       Impact factor: 7.738

Review 3.  Labetalol: a review of its pharmacology and therapeutic use in hypertension.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-04       Impact factor: 9.546

4.  Changes in glomerular filtration rate during long-term treatment with propranolol in patients with arterial hypertension.

Authors:  H Ibsen; P Sederberg-Olsen
Journal:  Clin Sci       Date:  1973-02       Impact factor: 6.124

5.  Labetalol in the treatment of a patient with phaechromocytoma: a case report.

Authors:  R R Bailey
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

6.  Measurement of glomerular filtration rate using a single injection of 51Cr-Edetic acid.

Authors:  R R Bailey; T G Rogers; J J Tait
Journal:  Australas Ann Med       Date:  1970-08

7.  Treatment of hypertensive emergencies with oral labetalol.

Authors:  R R Ghose; Y B Mathur; M Upadhyay; W D Morgan; S Khan
Journal:  Br Med J       Date:  1978-07-08

Review 8.  Pharmacological effects of labetalol in man.

Authors:  D A Richards
Journal:  Br J Clin Pharmacol       Date:  1976-08       Impact factor: 4.335
  8 in total
  12 in total

1.  Labetalol, an alpha- and beta-adrenoceptor-blocking agent: its use in therapeutics. A summary of the symposium.

Authors:  B N Prichard; D A Richards
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

2.  Labetolol in patients with hypertension and varying degrees of renal impairment.

Authors:  E G Breen; M Lombard; A Watson; J A Keogh
Journal:  Ir J Med Sci       Date:  1984-10       Impact factor: 1.568

3.  Labetalol and renal function.

Authors:  A Watson; K Maher; J A Keogh
Journal:  Ir J Med Sci       Date:  1981-06       Impact factor: 1.568

Review 4.  Clinical pharmacokinetics of labetalol.

Authors:  J J McNeil; W J Louis
Journal:  Clin Pharmacokinet       Date:  1984 Mar-Apr       Impact factor: 6.447

Review 5.  Labetalol. A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in hypertension and ischaemic heart disease.

Authors:  K L Goa; P Benfield; E M Sorkin
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

6.  Alternatives to beta-blockade in therapy of hypertension with angina pectoris: role of nifedipine or of labetalol.

Authors:  L H Opie; D White; J Lee; W F Lubbe
Journal:  Br J Clin Pharmacol       Date:  1982-06       Impact factor: 4.335

7.  Elimination kinetics of labetalol in severe renal failure.

Authors:  A J Wood; D G Ferry; R R Bailey
Journal:  Br J Clin Pharmacol       Date:  1982-06       Impact factor: 4.335

Review 8.  Combined alpha- and beta-receptor inhibition in the treatment of hypertension.

Authors:  B N Prichard
Journal:  Drugs       Date:  1984       Impact factor: 9.546

Review 9.  Pharmacology of combined alpha-beta-blockade. I.

Authors:  W J Louis; J J McNeil; O H Drummer
Journal:  Drugs       Date:  1984       Impact factor: 9.546

10.  Labetalol in severe and resistant hypertension.

Authors:  L C Williams; M J Murphy; V Parsons
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.